Survey among healthcare professionals (neurologists treating patients with MS along with MS specialist nurses) and patients in selected European countries plus Canada to evaluate the knowledge required for the safe use of Mayzent (siponimod)

22/12/2021
18/12/2025
EU PAS number:
EUPAS44782
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

CBAF312A2006-Amended protocol v1.4_Clean version_29Mar2021_Redacted

English (569.96 KB - PDF) View document
Updated protocol

CBAF312A2006_ProtocolAmendment_V3_25Jan2024_Clean Version_Redacted.pdf

First published: 29/05/2024
English (400.87 KB - PDF) View document
Study results
Study report
Study report

baf312a2006-CSR.pdf

English (1.31 MB - PDF) View document
Other information